References
1. Ametov A.S. Type 2 diabetes mellitus. Problems and solutions. Moscow: GEOTAR-Media; 2015. (in Russian)
2. IDF Atlas, 2017.
3. Diabetes mellitus: diagnosis, treatment, prevention. In: I.I. Dedov, M.V. Shestakova. Moscow: Meditsinskoe informatsionnoe agentstvo, 2011. (in Russian)
URL: http://eunidiaacademia.ru/files/fileUploader/ucebnik2.pdf
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes oh the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-86.
5. Dreval’ A.V., Dreval’ O.A., Starostina E.G. Continuous monitoring blood glucose level in clinical practice and new methods for its analysis. Problemy endokrinologii [Problems of Endocrinology]. 2013; (4): 41-9. (in Russian)
6. Klimontov V.V., Myakina N.E. Glycaemic variability: a tool for assessing the quality of glycaemic control and the risk of complications. Sakharniy diabet [Diabetes Mellitus]. 2014; (2): 76-82. (in Russian)
7. Standards of specialized diabetes care. 8th ed. In: I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. Moscow, 2017. (in Russian)
8. Antsiferov M.B., Sherntaner G. Current approaches to the treatment of type 2 diabetes in the era of new data on cardiovascular safety. Farmateka [Pharmateca]. 2016; (16): 8-16. (in Russian)
9. Little R.R. Glycated hemoglobin standardization - National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med. 2003; 41 (9): 1191-8.
10. Jeppsson J.O., kobold U., Barr J., et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002; 40: 78-89.
11. Clarke S.F., Foster J.R. The history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012; 69: 83-93.
12. Danne T., Nimri R., Battelino T., et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017; 40: 1631-40.
13. Grady M., Katz L.B., Strunk C.S., et al. Examining the impact of a novel blood glucose monitor with color range indicator on decision-making in patients with type 1 and type 2 diabetes and its association with patient numeracy level. JMIR Diabetes. 2017; 2 (2): 24.
14. Kato N., Cui J., Kato M. Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes. J Diabetes Investig. 2013; 4 (5): 450-3.
15. Haak T., Hanaire H., Ajjan R. et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017; 8 (1): 55-73.
URL: https://www.ncbi.nlm.nih.gov/pubmed/28000140
DOI: 10.1007/s13300-016-0223-6
16. Reiterer F., Polterauer P, Schoemaker M., et al. Significance and reliability of MARD for the accuracy of CGM systems. J Diabetes Sci Technol. 2017; 11 (1): 59-67.
URL: https://www.ncbi.nlm.nih.gov/pubmed/27566735
DOI: 10.1177/1932296816662047
17. Parkin C.G., Graham C., Smolskis J. Сontinuous glucose monitoring use in type 1 diabetes: longitudinal analysis demonstrates meaningful improvements in HbA1c and reductions in health care utilization. J Diabetes Sci Technol. 2017; 11 (3): 522-8.
URL: https://www.ncbi.nlm.nih.gov/pubmed/28745091
DOI: https://doi.org/10.1177/1932296817693253
18. Pickup J.C., Freeman S.Z., Sutton A.J. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011; 343: d3805.
URL: https://www.ncbi.nlm.nih.gov/pubmed/21737469
DOI: 10.1136/bmj.d3805
19. Evans J.M., Mackison D., Swanson V., Donnan P.T., et al. Selfmonitoring among non-insulin treated patients with type 2 diabetes mellitus: patients’ behavioural responses to readings and associations with glycaemic control. Diabetes Res Clin Pract. 2013: 100 (2): 235-42.
20. Shengsheng Y., Biju V., Zhiyi L., et al. Healthcare resource waste associated with patient nonadherence and early discontinuation of traditional continuous glucose monitoring in real-world setting: a multicountry analysis. Diabetes Technol Ther. 2018; 20: 420-7.